Acute Effects of Alpha-glycerylphosphorylcholine (A-GPC) on Lower Body Muscular Performance.

Part of paid clinical trials in DeKalb, Illinois.

Sponsor
Northern Illinois University
Study ID
NCT07397273
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Healthy Adult Participants

Eligibility Criteria

Sex
MALE
Age
19 Years - 29 Years
Healthy Volunteers
Accepted

Interventions

  • L-Alpha glycerylphosphorylcholine — DIETARY_SUPPLEMENT
    Oral, 900 mg, single dose study
  • Microcrystalline Cellulose — DIETARY_SUPPLEMENT
    Oral, 900 mg, single dose study

Study Details

The purpose of the present study was to examine the effectiveness of acute A-GPC supplementation on upper and lower body muscular strength, endurance, power, and global levels of activation.

Key Dates

Start date
Mar 16, 2026
Status verified
Feb 2026
Primary completion
May 16, 2026
Completion
May 16, 2026

Study Design

Enrollment
20 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: Supplement group
    Oral Alpha-GPC (900 mg)
  • Placebo Comparator: Placebo group
    Oral microcrystalline cellulose

Primary Outcome Measure

Maximal Voluntary Isometric Contraction [ Time Frame: Approximately 90 minutes post-ingestion of condition ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Northern Illinois UniversityDeKalbIllinois60115
Clayton Camic, PHD
[email protected]
3077607449
Matteo de Leon, BS
[email protected]
224-864-0044

Find similar trials in DeKalb, IL

By research site
Northern Illinois University· DeKalb, IL

Related Studies